TNF and congestive heart failure: Therefore, it is not surprising that clinical chronic heart failure trials, employing compounds antagonizing TNFα (including the TNFα-binding antibody infliximab and the soluble recombinant TNFα-receptor etanercept) revealed disappointing results [28].